281 related articles for article (PubMed ID: 31376208)
1. Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on.
Mohanty S; Aghighi M; Yerneni K; Theruvath JL; Daldrup-Link HE
Mol Oncol; 2019 Oct; 13(10):2049-2061. PubMed ID: 31376208
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma.
Mohanty S; Yerneni K; Theruvath JL; Graef CM; Nejadnik H; Lenkov O; Pisani L; Rosenberg J; Mitra S; Cordero AS; Cheshier S; Daldrup-Link HE
Cell Death Dis; 2019 Jan; 10(2):36. PubMed ID: 30674867
[TBL] [Abstract][Full Text] [Related]
3. Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy.
Roudi R; Pisani L; Pisani F; Kiru L; Daldrup-Link HE
Invest Radiol; 2024 May; 59(5):391-403. PubMed ID: 37812494
[TBL] [Abstract][Full Text] [Related]
4. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
5. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal.
Liu M; O'Connor RS; Trefely S; Graham K; Snyder NW; Beatty GL
Nat Immunol; 2019 Jan; 20(3):265-275. PubMed ID: 30664738
[TBL] [Abstract][Full Text] [Related]
6. Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody.
Ni H; Cao L; Wu Z; Wang L; Zhou S; Guo X; Gao Y; Jing H; Wu M; Liu Y; Ding J; Zhang P; Zhou Y; Chen B; Xiong Y; Sun J; Prinz B; Baruah H; Geoghegan J; Yu M; Wu W; Liu J
Cancer Immunol Immunother; 2022 Feb; 71(2):353-363. PubMed ID: 34165607
[TBL] [Abstract][Full Text] [Related]
7. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Theruvath J; Menard M; Smith BAH; Linde MH; Coles GL; Dalton GN; Wu W; Kiru L; Delaidelli A; Sotillo E; Silberstein JL; Geraghty AC; Banuelos A; Radosevich MT; Dhingra S; Heitzeneder S; Tousley A; Lattin J; Xu P; Huang J; Nasholm N; He A; Kuo TC; Sangalang ERB; Pons J; Barkal A; Brewer RE; Marjon KD; Vilches-Moure JG; Marshall PL; Fernandes R; Monje M; Cochran JR; Sorensen PH; Daldrup-Link HE; Weissman IL; Sage J; Majeti R; Bertozzi CR; Weiss WA; Mackall CL; Majzner RG
Nat Med; 2022 Feb; 28(2):333-344. PubMed ID: 35027753
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation.
Aghighi M; Theruvath AJ; Pareek A; Pisani LL; Alford R; Muehe AM; Sethi TK; Holdsworth SJ; Hazard FK; Gratzinger D; Luna-Fineman S; Advani R; Spunt SL; Daldrup-Link HE
Clin Cancer Res; 2018 Sep; 24(17):4110-4118. PubMed ID: 29764855
[No Abstract] [Full Text] [Related]
9. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.
Abdel-Bar HM; Walters AA; Lim Y; Rouatbi N; Qin Y; Gheidari F; Han S; Osman R; Wang JT; Al-Jamal KT
Theranostics; 2021; 11(18):8738-8754. PubMed ID: 34522209
[No Abstract] [Full Text] [Related]
10. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z
Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma.
Lo J; Lau EY; So FT; Lu P; Chan VS; Cheung VC; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK
Liver Int; 2016 May; 36(5):737-45. PubMed ID: 26351778
[TBL] [Abstract][Full Text] [Related]
12. The development of small-molecule inhibitors targeting CD47.
Yu WB; Ye ZH; Chen X; Shi JJ; Lu JJ
Drug Discov Today; 2021 Feb; 26(2):561-568. PubMed ID: 33197622
[TBL] [Abstract][Full Text] [Related]
13. Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer.
Tian L; Xu B; Teng KY; Song M; Zhu Z; Chen Y; Wang J; Zhang J; Feng M; Kaur B; Rodriguez L; Caligiuri MA; Yu J
Clin Cancer Res; 2022 Jan; 28(1):201-214. PubMed ID: 34645647
[TBL] [Abstract][Full Text] [Related]
14. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer.
Michaels AD; Newhook TE; Adair SJ; Morioka S; Goudreau BJ; Nagdas S; Mullen MG; Persily JB; Bullock TNJ; Slingluff CL; Ravichandran KS; Parsons JT; Bauer TW
Clin Cancer Res; 2018 Mar; 24(6):1415-1425. PubMed ID: 29288236
[No Abstract] [Full Text] [Related]
15. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
[TBL] [Abstract][Full Text] [Related]
16. Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.
Liu J; Wang L; Zhao F; Tseng S; Narayanan C; Shura L; Willingham S; Howard M; Prohaska S; Volkmer J; Chao M; Weissman IL; Majeti R
PLoS One; 2015; 10(9):e0137345. PubMed ID: 26390038
[TBL] [Abstract][Full Text] [Related]
17. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
[TBL] [Abstract][Full Text] [Related]
18. Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade.
Anderson KL; Snyder KM; Ito D; Lins DC; Mills LJ; Weiskopf K; Ring NG; Ring AM; Shimizu Y; Mescher MF; Weissman IL; Modiano JF
Melanoma Res; 2020 Apr; 30(2):147-158. PubMed ID: 31205227
[TBL] [Abstract][Full Text] [Related]
19. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.
Nishiga Y; Drainas AP; Baron M; Bhattacharya D; Barkal AA; Ahrari Y; Mancusi R; Ross JB; Takahashi N; Thomas A; Diehn M; Weissman IL; Graves EE; Sage J
Nat Cancer; 2022 Nov; 3(11):1351-1366. PubMed ID: 36411318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
